METASTATIC MALIGNANT NEOPLASM IN THE BONE
Clinical trials for METASTATIC MALIGNANT NEOPLASM IN THE BONE explained in plain language.
Never miss a new study
Get alerted when new METASTATIC MALIGNANT NEOPLASM IN THE BONE trials appear
Sign up with your email to follow new studies for METASTATIC MALIGNANT NEOPLASM IN THE BONE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted attack on returning prostate cancer shows promise
Disease control OngoingThis study is testing whether a combination of surgery and radiation can control prostate cancer that has returned or spread to a few other places in the body. It involves 20 men whose cancer has come back after initial treatment. The goal is to see if this targeted approach can …
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE BONE
Phase: PHASE2 • Sponsor: University of Utah • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Radioactive drug joins fight against breast cancer in bones
Disease control OngoingThis study is testing whether adding a radioactive drug called Radium-223 to standard chemotherapy (paclitaxel) works better for people with breast cancer that has spread to their bones. The radioactive drug travels to the bones and aims to kill cancer cells there, potentially sl…
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE BONE
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New hope for rare bone cancer: major trial tests drug to stop tumor growth
Disease control OngoingThis large, late-stage trial is testing if adding a new drug called ganitumab to standard chemotherapy helps patients with newly diagnosed Ewing sarcoma that has spread. Ganitumab is designed to block a pathway that helps tumor cells grow. The study aims to see if this combinatio…
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE BONE
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Smart scans aim to target deadly prostate cancer spread
Disease control OngoingThis study is testing whether a special type of imaging scan (PSMA PET) can help doctors better select patients for a targeted radiation treatment called Ra-223. The treatment is for men whose prostate cancer has become resistant to hormone therapy and has spread to their bones. …
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE BONE
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Mar 16, 2026 15:27 UTC
-
Targeted radiation joins fight against bone pain in advanced kidney cancer
Disease control OngoingThis study is for people with advanced kidney cancer that has spread to their bones. It tests if adding a radioactive drug (radium-223) to a standard cancer pill (cabozantinib) works better than the pill alone. The main goal is to see if the combination can delay bone-related pro…
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE BONE
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 12, 2026 13:50 UTC
-
Major trial aims to boost survival for advanced kidney cancer
Disease control OngoingThis large, late-stage trial is testing if adding a drug called cabozantinib to a standard immunotherapy regimen helps patients with advanced kidney cancer that has spread. The study will compare how long patients live and how long their cancer is controlled on the new combinatio…
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE BONE
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC